ClinicalTrials.gg
TerminatedNCT03316105Updated May 30, 2019Results posted

Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers

An interventional study of Elira Investigational TENS device in Weight Loss, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-30.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Basic science

Why this study was terminated
Electrical device malfunction; recruitment was stopped.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 15 studies in Weight Loss by Mayo Clinic — 1 open to participants now, 2 under way, none of them phase 3. Weight Loss · Mayo Clinic.

Enrollment
10th of 13
16 · median 46
Started
2017
with 1 other
No phase
7 of 15
none open now
Registered
9th of 15
by date

Among the 15 studies in Weight Loss by Mayo Clinic, this one is the 10th largest by enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2017, is one of 7 with no phase, and was the 9th registered.

Weight Loss

1,815 studies on the registry are indexed under Weight Loss; 294 are open to participants now.

Browse Weight Loss studies →

Open to participants now

1 of the 15 studies in Weight Loss by Mayo Clinic is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 196 Weight Loss studies recruiting now, 71 (36%) set no upper age limit and 108 (55%) stop at 75 or younger; 21 take children under 18; 58 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Weight Loss by Mayo Clinic, or all of them as a file.
02

Study summary

The investigators are doing this research study to find out the effect of T6 Dermatomal Electrical Stimulation (delivered by a Transcutaneous Electrical Nerve Stimulation (TENS) unit) on stomach motor activity.

03

Conditions studied

  • Weight Loss

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy volunteers with ≤34.99 kg/m\^2 residing within 125 miles of Mayo Clinic in Rochester, Minnesota; these will be healthy individuals with no unstable psychiatric disease and not currently on treatment for cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, neurological, or endocrine (other than hyperglycemia on diet) disorders.
  2. Women of will be using an effective form of , and have negative pregnancy tests within 48 hours of the test day.
  3. Subjects must have the ability to provide before any trial-related activities.
  4. Eligible individuals will be asked to avoid taking additional medications and supplements for one week before and after the test day, unless reviewed and approved by the study team.

Exclusion criteria

Exclusion Criteria:

  1. Abdominal surgery other than appendectomy, Caesarian section or tubal ligation.
  2. Positive history of chronic gastrointestinal diseases, systemic disease that could affect gastrointestinal motility, or use of medications that may alter gastrointestinal motility.
  3. Positive history of spinal cord injury and/or chronic back pain.
  4. Significant untreated psychiatric dysfunction based upon screening with the Hospital Anxiety and Depression Inventory (HAD). If such a dysfunction is identified by a HAD score >11 on either Anxiety or Depression or difficulties with substance or eating disorders, the participant will be excluded and given a referral letter to his/her primary care doctor for further appraisal and follow-up.
  5. Intake of medication, whether prescribed or over the counter (except multivitamins), within 7 days of the study. Exceptions are pill, estrogen replacement therapy, thyroxine replacement therapy, low dose analgesia or anti-inflammatory medications (Acetaminophen and Ibuprofen) and any medication administered for co-morbidities as long as they do not alter gastrointestinal motility.
  6. Subjects may also be excluded from participation for other factors at the discretion of the principal investigator.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
16 participants (actual)

Study arms

  • Active comparator
    Transcutaneous electrical nerve stimulation (TENS) stimulation

    During this TENS unit stimulation arm, subjects will have a narrow tube (about the diameter of a telephone cord) placed into the subjects small intestine by the study physician and trained technician. The technician will use a small amount of fluoroscopy (radiation) to make sure the tube is placed in the proper position. About one hour after the tube has been placed subjects will be given a breakfast meal. The narrow tube (GDM) will take pressure readings after being placed. After four hours, subjects will again be given a second meal. Fifteen minutes of electrical stimulation will be given to subjects fifteen minutes before ingestion of lunch. After ingestion of lunch, 60 minutes of the electrical stimulation will be applied. When the test is done, the tube will be removed.

    Device: Elira Investigational TENS device

  • Sham comparator
    No TENS stimulation

    During this no TENS unit stimulation arm, subjects will have a narrow tube (about the diameter of a telephone cord) placed into the subjects small intestine by the study physician and trained technician. The technician will use a small amount of fluoroscopy (radiation) to make sure the tube is placed in the proper position. About one hour after the tube has been placed subjects will be given a breakfast meal. The narrow tube (GDM) will record stomach pressure readings after being placed. After four hours, subjects will again be given a second meal. The TENS unit stimulation will be placed but no electrical stimulation will be given. When the test is done, the tube will be removed.

    Device: Elira Investigational TENS device

Interventions

  • DeviceElira Investigational TENS device

    TENS unit placed on skin will deliver electric stimulation to abdominal area.

    Also known as: Electric Stimulation from TENS unit

06

What researchers measure

Primary outcomes

  1. The Effect of T6 Dermatomal Electrical Stimulation on Subjects Stomach Motor Activity

    Testing to see if dermatomal electrical stimulation will speed up or slow down the stomach motor activity.

    Time frame: through study completion, an average of 1 year

07

Results

Posted May 30, 2019

Participant flow

Participant flow — Overall Study
MilestoneTranscutaneous Electrical Nerve Stimulation (TENS) StimulationNo TENS Stimulation
Started97
Completed97
Not completed00

Outcome measures

PrimaryThe Effect of T6 Dermatomal Electrical Stimulation on Subjects Stomach Motor Activity

Testing to see if dermatomal electrical stimulation will speed up or slow down the stomach motor activity.

Time frame:
through study completion, an average of 1 year

No measurements were reported for this outcome.

Adverse events

Collected over Adverse Events were assessed through study completion, an average of 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
TENS Unit Stimulation0/9 (0%)0/9 (0%)0/9 (0%)
No TENS Unit Stimulation0/7 (0%)0/7 (0%)0/7 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)TENS Unit StimulationNo TENS Unit StimulationTotal
Mean40.1 ± 11.634 ± 7.936.6 ± 10.0
Sex: Female, Male
Sex: Female, Male(Participants)TENS Unit StimulationNo TENS Unit StimulationTotal
Female538
Male448
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)TENS Unit StimulationNo TENS Unit StimulationTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)TENS Unit StimulationNo TENS Unit StimulationTotal
United States9716
08

Study locations

1 site
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2017 to primary completion in Jun 2018, 9 months.

Results were first posted in May 2019, 11 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2017
First posted
Oct 20, 2017
StartActual
Sep 6, 2017
Primary completionActual
Jun 21, 2018
CompletionActual
Jun 21, 2018
Results first posted
May 30, 2019
Last update
May 30, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 30, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03316105
Lead sponsor
Mayo Clinic
Collaborators
Elira Therapeutics, Inc.
Responsible party
Michael Camilleri, MD (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Oct 20, 2017
Start date
Sep 6, 2017
Primary completion
Jun 21, 2018
Completion
Jun 21, 2018
Results posted
May 30, 2019
Last update
May 30, 2019

Study contacts

Michael Camilleri, M.D
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion